Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
LabCorp's earnings call took place on the heels of a media report earlier this month that the company was in discussions to buy Pharmaceutical Product Development.
The contract research organization has been viewed as a logical takeout target of LabCorp. for some time now.
Trade-Ideas LLC identified Laboratory Corp of America Holdings (LH) as a new lifetime high candidate